Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 30Observational 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4Prostatic Hyperplasia 2Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Dutasteride × Clear all
NCT01594502 2020-10-12

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

University of Illinois at Chicago

Completed
139 enrolled
Genitourinary

Prostatic Neoplasms

NCT00883909 2017-07-11

ARI103094-Follow-Up Study for REDUCE Study Subjects

GlaxoSmithKline

Completed
2,795 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT01337258 2017-05-30

Economic Analyses of the REDUCE Trial

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

NCT01525914 2012-02-03

Response of Patients on Surveillance for Prostate Cancer to Dutasteride

Sunnybrook Health Sciences Centre

Completed
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡